Jennifer King

1.3k total citations · 1 hit paper
35 papers, 646 citations indexed

About

Jennifer King is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Jennifer King has authored 35 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 12 papers in Pulmonary and Respiratory Medicine and 10 papers in Neurology. Recurrent topics in Jennifer King's work include Testicular diseases and treatments (13 papers), Sarcoma Diagnosis and Treatment (9 papers) and Neuroblastoma Research and Treatments (6 papers). Jennifer King is often cited by papers focused on Testicular diseases and treatments (13 papers), Sarcoma Diagnosis and Treatment (9 papers) and Neuroblastoma Research and Treatments (6 papers). Jennifer King collaborates with scholars based in United States, Belgium and Canada. Jennifer King's co-authors include Alan Shiels, Milam A. Brantley, Steven Kymes, T S Hays, R. Bruce Nicklas, Asheesh Tewari, Clivel G. Charlton, Hongtao Chen, Eun-Sook Lee and Donna S. Mackay and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Cell Biology and Cancer Research.

In The Last Decade

Jennifer King

29 papers receiving 624 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chronic kidney disease–mineral and bone disorder: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

2025 24 citations Markus Ketteler, Pieter Evenepoel et al. Kidney International profile →

Peers

Countries citing papers authored by Jennifer King

Since Specialization

Citations

This map shows the geographic impact of Jennifer King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer King more than expected).

Fields of papers citing papers by Jennifer King

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer King. The network helps show where Jennifer King may publish in the future.

Co-authorship network of co-authors of Jennifer King

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer King. A scholar is included among the top collaborators of Jennifer King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer King. Jennifer King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preventing chronic kidney disease and maintaining kidney health: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference 2025 ·Kidney International ·Alberto Ortíz, María José Guerra Palmero, Juliana C.N. Chan, (unknown), Holly Kramer, Susanne B. Nicholas, Meda E. Pavkov, Christoph Wanner, Leslie P. Wong, Michael Cheung, Jennifer King, Morgan E. Grams, Michel Jadoul, Katherine R. Tuttle, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	3
2	Women and kidney health: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference 2025 ·Kidney International ·Giorgina Barbara Piccoli, Sofia B. Ahmed, Fádi Fakhouri, Vesna D. Garovic, Michelle Hladunewich, Shilpanjali Jesudason, Jai Prakash, Angela C Webster, Elena Zakharova, Michael Cheung, Jennifer King, Michel Jadoul, Wolfgang C. Winkelmayer, Christina Wyatt, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2
3	Chronic kidney disease–mineral and bone disorder: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Сonference 2025 ·Pure Amsterdam UMC ·Markus Ketteler, Pieter Evenepoel, (unknown), Tamara Isakova, Hanne Skou Jørgensen, Hirotaka Komaba, Thomas L. Nickolas, Smeeta Sinha, Marc Vervloet, Michael Cheung, Jennifer King, Morgan E. Grams, Michel Jadoul, Rosa Maria Affonso Moysés, (unknown)	0
4	Neuropathy, skin rash, and hyperglycemia as predictors of response to enfortumab vedotin in locally advanced and metastatic bladder and upper tract urothelial carcinoma. 2025 ·Journal of Clinical Oncology ·(unknown), (unknown), Sandra K. Althouse, (unknown), Jennifer King, Nabil Adra	0
5	Management of Residual Nonretroperitoneal Disease in Postchemotherapy Nonseminomatous Germ-Cell Tumors 2023 ·Journal of Clinical Oncology ·Jennifer King, (unknown), Kenneth A. Kesler, (unknown), Sandra K. Althouse, Nasser H. Hanna, Lawrence H. Einhorn, Nabil Adra	4
6	Multimodality, online oncology learning resources: Meeting residents where they are—A pilot to create a new oncology curriculum. 2023 ·Journal of Clinical Oncology ·Jennifer King, Phillip Pham, Ahmed Bilal Khalid, (unknown), Jennifer E. Schwartz	0
7	Bone metastasis in patients with germ-cell tumors: Analysis of survival outcomes and prognostic factors. 2023 ·Journal of Clinical Oncology ·(unknown), Jennifer King, Sandra K. Althouse, Nasser H. Hanna, Lawrence H. Einhorn, Nabil Adra	1
8	Postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) for seminoma: Limitations of surgical intervention after first-line chemotherapy 2023 ·Urologic Oncology Seminars and Original Investigations ·Isamu Tachibana, (unknown), Rumeal D. Whaley, (unknown), (unknown), (unknown), (unknown), Jennifer King, Nabil Adra, Kevin R. Rice, Richard S. Foster, Lawrence H. Einhorn, Clint Cary, Timothy A. Masterson	2
9	Surveillance after Complete Response to First-Line Chemotherapy in Patients with Metastatic Nonseminomatous Germ Cell Tumor 2022 ·The Journal of Urology ·Jennifer King, Sandra K. Althouse, Clint Cary, Timothy A. Masterson, Richard S. Foster, (unknown), Nasser H. Hanna, Lawrence H. Einhorn, Nabil Adra	1
10	Current Status of Stem Cell Transplant in Treatment of Testicular Germ Cell Tumors 2022 ·Current Oncology Reports ·Jennifer King, Nabil Adra	4
11	Can Retroperitoneal Lymph Node Dissection (RPLND) be feasibly performed to prolong survival in Renal Cell Carcinoma (RCC) with limited lymph node involvement? An Analysis of Recurrence Patterns 2022 ·Urologic Oncology Seminars and Original Investigations ·Isamu Tachibana, (unknown), (unknown), (unknown), (unknown), Jennifer King, Nabil Adra, Ronald S. Boris, Clint Cary, Kevin R. Rice	1
12	Innovation in Resident Core Oncology Education: Switching from an Inpatient Ward Rotation to a Hybrid Model of Inpatient Consultations and Outpatient Clinics 2021 ·Journal of Cancer Education ·Jennifer King, (unknown), Antoine N. Saliba, (unknown), (unknown), Naveen Manchanda, (unknown), Sara J. Grethlein, Mitchell Goldman	1
13	Substance use disorders in adolescent and young adult relatives of probands with bipolar disorder: What drives the increased risk? 2017 ·Comprehensive Psychiatry ·Leslie A. Hulvershorn, Jennifer King, Patrick O. Monahan, Holly C. Wilcox, Philip B. Mitchell, Janice M. Fullerton, Howard J. Edenberg, Gloria Roberts, Masoud Kamali, Anne L. Glowinski, Neera Ghaziuddin, Melvin G. McInnis, (unknown), John I. Nürnberger	7
14	Effects of acute and sub-chronic l-dopa therapy on striatal l-dopa methylation and dopamine oxidation in an MPTP mouse model of Parkinsons disease 2014 ·Life Sciences ·(unknown), Jennifer King, (unknown), (unknown), (unknown), (unknown), Clivel G. Charlton	8
15	Prenatal exposure to methanol as a dopamine system sensitization model in C57BL/6J mice 2012 ·Life Sciences ·(unknown), (unknown), (unknown), Jennifer King, Clivel G. Charlton	1
16	Modeling a sensitization stage and a precipitation stage for Parkinson's disease using prenatal and postnatal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration 2010 ·Neuroscience ·Gladson Muthian, (unknown), Jennifer King, Clivel G. Charlton	18
17	Chemotherapy Follow-Up in Older Adults 2010 ·Clinical journal of oncology nursing ·(unknown), (unknown), Jennifer King	6
18	Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to photodynamic therapy 2008 ·Eye ·Milam A. Brantley, Sean L. Edelstein, Jennifer King, Michael Plotzke, Rajendra S. Apte, Steven Kymes, Alan Shiels	66
19	The Role of 3-O-Methyldopa in the Side Effects of l-dopa 2007 ·Neurochemical Research ·Eun-Sook Lee, Hongtao Chen, Jennifer King, Clivel G. Charlton	47
20	Association of Complement Factor H and LOC387715 Genotypes with Response of Exudative Age-Related Macular Degeneration to Intravitreal Bevacizumab 2007 ·Ophthalmology ·Milam A. Brantley, (unknown), Jennifer King, Asheesh Tewari, Steven Kymes, Alan Shiels	158

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact